TripathiNM, BandyopadhyayA. High throughput virtual screening (HTVS) of peptide library: Technological advancement in ligand discovery. Eur J Med Chem, 2022; 243:114766.
2.
ShiS, FuL, YiJ, et al.ChemFH: An integrated tool for screening frequent false positives in chemical biology and drug discovery. Nucleic Acids Res, 2024; 52(W1):W439–W449.
3.
LynchC, SakamuruS, OokaM, et al.High-throughput screening to advance in vitro toxicology: Accomplishments, challenges, and future directions. Annu Rev Pharmacol Toxicol, 2024; 64:191–209.
4.
Fredin HaslumJ, LardeauCH, KarlssonJ, et al.Cell Painting-based bioactivity prediction boosts high-throughput screening hit rates and compound diversity. Nat Commun, 2024; 15(1):3470.
5.
NelmsMD, AntonijevicT, RingC, et al.Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models. Front Toxicol, 2024; 6:1346767.
6.
KarRK. High-throughput and computational techniques for aptamer design. Expert Opin Drug Discov, 2024; 19(12):1457–1469.
7.
NingH, BoyesI, NumanagićI, et al.Diagnostics of viral infections using high-throughput genome sequencing data. Brief Bioinform, 2024; 25(6):bbae501.
8.
LinoBR, WilliamsSJ, CastorME, et al.Reaching new heights in genetic code manipulation with high-throughput screening. Chem Rev, 2024; 124(21):12145–12175.
9.
YongH, WeiD, TangY, et al.Numerical modelling of electromechanical coupling behaviors in HTS coil with implementation of H formulation in FE software. Superconductivity, 2024; 10:100097.
10.
TalrejaS, TiwariS. From one to millions: The revolution of combinatorial chemistry. J Anal Tech Res, 2024; 6(2):37–42.
11.
ZhangY, GaoZ, YangX, et al.Leveraging high-throughput screening technologies in targeted mRNA delivery. Mater Today Bio, 2024; 26:101101.
12.
LiY, BowlingAJ, LehmanA, et al.High-throughput image-based assay for identifying in vitro hepatocyte microtubule disruption. J Agric Food Chem, 2024; 72(39):21804–21819.
13.
PouliotM, JeanmartS. Pan assay interference compounds (PAINS) and other promiscuous compounds in antifungal research: Miniperspective. J Med Chem, 2016; 59(2):497–503.
14.
JasialS, HuY, BajorathJ. How frequently are pan-assay interference compounds active? Large-scale analysis of screening data reveals diverse activity profiles, low global hit frequency, and many consistently inactive compounds. J Med Chem, 2017; 60(9):3879–3886.
15.
HasnatS, RahmanS, AlamMB, et al.High-throughput screening identifies potential inhibitors targeting trimethoprim-resistant DfrA1 protein in Klebsiella pneumoniae and Escherichia coli. Sci Rep, 2025; 15(1):7141–7152.
16.
YinG, ZhuH, ChenS, et al.Machine learning-assisted high-throughput screening for electrocatalytic hydrogen evolution reaction. Molecules, 2025; 30(4):759–776.
17.
WellnitzJ, JainS, HochuliJE, et al.One size does not fit all: Revising traditional paradigms for assessing accuracy of QSAR models used for virtual screening. J Cheminform, 2025; 17(1):7–17.
18.
HeyseS, BrodteA, BruttgerO, et al.Quantifying bioactivity on a large scale: Quality assurance and analysis of multiparametric ultra-HTS data. JALA: J Assoc Lab Autom, 2005; 10(4):207–212.
19.
AbrahamY, ZhangX, ParkerCN. Multiparametric analysis of screening data: Growing beyond the single dimension to infinity and beyond. J Biomol Screen, 2014; 19(5):628–639.
20.
HansjostenI, RappJ, ReinerL, et al.Microscopy-based high-throughput assays enable multi-parametric analysis to assess adverse effects of nanomaterials in various cell lines. Arch Toxicol, 2018; 92(2):633–649.
